IMV Inc. to Announce Second Quarter 2018 Financial Results and Host Earnings Call on August 8, 2018
July 31 2018 - 6:05AM
IMV Inc. (“IMV” or the “Corporation”) (Nasdaq:IMV) (TSX:IMV), a
clinical stage immunotherapy company, announced today that it will
hold a conference call and webcast on Wednesday, August 8, 2018 at
8:00 a.m. ET to discuss the company’s second quarter financial and
operational results.
The dial-in number for the conference call is (844) 461-9932
(U.S. and Canada) or (636) 812-6632 (international) with the
conference ID: 6583235. Those interested can access the live audio
webcast at this link: https://edge.media-server.com/m6/p/xt8xgtjx.
The webcast will be recorded and available on the IMV website for
30 days following the call.
About IMV
IMV Inc., formerly Immunovaccine, is a
clinical stage biopharmaceutical company dedicated to making
immunotherapy more effective, more broadly applicable, and more
widely available to people facing cancer and other serious
diseases. IMV is pioneering a new class of immunotherapies based on
the Company’s proprietary drug delivery platform. This patented
technology leverages a novel mechanism of action that enables the
reprogramming of immune cells in vivo, which are aimed at
generating powerful new synthetic therapeutic capabilities. IMV’s
lead candidate, DPX-Survivac, is a T cell activating immunotherapy
that combines the utility of the platform with a target: survivin.
IMV is currently conducting three Phase 2 studies with Incyte and
Merck assessing DPX-Survivac as a combination therapy in ovarian
cancer and diffuse large B-cell lymphoma. Connect
at www.imv-inc.com.
IMV Forward-Looking
Statements
This press release contains forward-looking
information under applicable Canadian and U.S. securities law. All
information that addresses activities or developments that we
expect to occur in the future is forward-looking information.
Although the Corporation believes the forward-looking statements in
this press release are reasonable, it can give no assurance that
the expectations and assumptions in such statements will prove to
be correct. The Corporation cautions investors that any
forward-looking statements by the Corporation are not guarantees of
future results or performance, and that actual results may differ
materially from those in forward-looking statements as a result of
various factors, including, but not limited to, the matters
discussed under “Risk Factors and Uncertainties” in IMV’s Annual
Information Form filed in Canada on March 20, 2018 on
www.sedar.com and included in the company’s Form 40-F filing in the
United States with the United States Securities and Exchange
Commission filed on May 1, 2018 on www.sec.gov. IMV Inc. assumes no
responsibility to update forward-looking statements in this press
release except as required by law.
Contacts for IMV:
MEDIA Mike Beyer, Sam Brown Inc. T: (312)
961-2502 E: mikebeyer@sambrown.com
INVESTOR RELATIONS Pierre Labbé, Chief
Financial Officer T: (902) 492-1819 E: info@imv-inc.com
Patti Bank, Managing Director, Westwicke
Partners O: (415) 513-1284 T: (415) 515-4572 E:
patti.bank@westwicke.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about IMV Inc (Toronto Stock Exchange): 0 recent articles
More News Articles